4//SEC Filing
Nagler David 4
Accession 0001209191-17-053350
CIK 0001628738other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:59 PM ET
Size
8.9 KB
Accession
0001209191-17-053350
Insider Transaction Report
Form 4
Nagler David
SVP, HR & Corp. Affairs
Transactions
- Exercise/Conversion
Common Stock
2017-09-15$2.19/sh+3,750$8,195→ 3,750 total - Exercise/Conversion
Stock Option (right to buy)
2017-09-15−3,750→ 41,097 totalExercise: $2.19Exp: 2025-02-04→ Common Stock (3,750 underlying) - Sale
Common Stock
2017-09-15$25.00/sh−3,750$93,750→ 0 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]The option vested as to 25% of the total shares on February 1, 2016, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on February 1, 2019, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
Audentes Therapeutics, Inc.
CIK 0001628738
Entity typeother
Related Parties
1- filerCIK 0001416175
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 5:59 PM ET
- Size
- 8.9 KB